Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced it will present a poster on one of the ...

Success in cancer care increasingly includes survivorship outcomes, emphasizing durable function and symptom control for patients cured and those with prolonged metastatic disease. Variable survival ...

Antibiotic use among patients with GI and liver cancers treated with ICI is linked to significantly worse OS, progression-free survival, and disease control rates.

India, March 17 -- A new medication called romiplostim can protect cancer patients from serious side effects of chemotherapy ...

The American Cancer Society estimates that over 55,000 people will die from colorectal cancer in the U.S. this year. Of those, 7% will be under 50.

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...

"Prevention and early detection remain some of the most powerful tools we have to reduce cancer risk in the future." ...

But the injectable drug romiplostim (Nplate) can effectively prevent chemo from causing thrombocytopenia, by boosting bone marrow cells’ ability to withstand the cancer treatment, researchers reported ...

Getting a timely scan within 48 hours for accident and emergency patients with blood in urine (hematuria) speeds up bladder cancer diagnosis and significantly saves lives.